Читать «Код убеждения (Как нейромаркетинг повышает продажи, эффективность рекламных кампаний и конверсию сайта)» онлайн - страница 170
Патрик Ренвуазе
54. Farrelly, M. C., Healton, C. G., Davis, K. C. et al. (2002). Getting to the truth: Evaluating national tobacco countermarketing campaigns.
55. Rothman, A. J., Martino, S. C., Bedell, B. T. et al. (1999). The systematic influence of gain- and loss-framed messages on interest in and use of different types of health behavior.
56. Detweiler, J.B., Bedell, B.T., Salovey, P. et al. (1999). Message framing and sunscreen use: Gain-framed messages motivate beach-goers.
57. Schneider, T.R., Salovey, P., Pallonen, U. et al. (2001). Visual and auditory message framing effects on tobacco smoking.
58. Schneider, T.R., Salovey, P., Apanovitch, A.M. et al. (2001). The effects of message framing and ethnic targeting on mammography use among low-income women.
59. Lang, A. (2000). The limited capacity model of mediated message processing.
60. Lang, A., Zhou, S., Schwartz, N. et al. (2000). The effects of edits on arousal, attention, and memory for television messages: When an edit is an edit can an edit be too much?
61. Stanovich, K. E. and West, R. F. (2000). Individual differences in reasoning:
62. Kahneman, D. (2011).
63. Benson, B. (2016). Cognitive bias cheat sheet, simplified.
64. Crocker, J. and Park, L. E. (2004). The costly pursuit of self-esteem.
65. Greenberg, J., Pyszczynski, T., Solomon, S. et al. (1993). Effects of self-esteem on vulnerability-denying defensive distortions: Further evidence of an anxiety-buffering function of self-esteem.
66. Kunda, Z. (1990). The case for motivated reasoning.
67. Haselton, M.G. and Nettle, D. (2006). The paranoid optimist: An integrative evolutionary model of cognitive biases.
68. Weinstein, N.D. (1980). Unrealistic optimism about future life events.
69. Gladwell, M. (2005).
70. Ariely, D. (2008).
71. Mundell, E.J., (2014). Scientists erase, then restore memories in rats.
72. Cory, G.A., (2002). MacLean’s evolutionary neuroscience, the CSN model and Hamilton’s rule: Some developmental clinical, and social policy implications.